Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Geneva Foundation, have developed a promising new vaccine candidate that protects against Lassa fever.
WuXi AppTec trims ‘small percentage’ of workers at US site as market shifts
WuXi AppTec is cutting a small number of roles at a facility in St. Paul, MN, a company spokesperson told Endpoints News in an email.